| Square Pharmaceuticals Ltd. | |
| Type: | Private |
| Industry: | Pharmaceutical |
| Founder: | Samson H. Chowdhury |
| Hq Location City: | Mohakhali, Dhaka |
| Hq Location Country: | Bangladesh |
| Area Served: | Asia, Africa, Europe, Central America, South America, Australia |
| Key People: | Tapan Chowdhury (CEO) |
| Revenue: | US$528 million (2019) |
| Operating Income: | US$254 million (2019) |
| Net Income: | US$156 million (2019) |
| Assets: | US$1.18 billion (2019) |
| Num Employees: | 7390 |
| Num Employees Year: | 2016-17 |
| Parent: | Square Group |
Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company.[1] It was founded in 1958[2] by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange[3] and on the Chittagong Stock Exchange (ID of SPL: 13002)[4] Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.[5]
In 2008 and 2009 it had the highest market share in the pharmaceutical industry of Bangladesh.[1] [6] For the last couple of years, it has been seeing double digit revenue every year.[7] the Forbes list said Square Pharmaceutical Company of Bangladesh, involved in drug and chemical business, has sales volume worth $512 million. The local pharma's market capital is $1.7 billion. Its net income is $150 million and has employed 9,240 people.